In AML, PD-1 expression was observed in T-cell subpopulations, including CD4+ T-effector cells, Tregs and CD8+ T cells, both in untreated patients and in patients with a recurrent disease [39]. This evidence concerns the gene PDCD1 and acute myeloid leukemia.